Drug: Buprenorphine transdermal delivery system: chronic pain clinical trials
Registry records that list "Drug: Buprenorphine transdermal delivery system" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
5
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
5 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study. NCT00313833 | Completed | Phase 3 | United States | Purdue Pharma LP | 2000-12 |
| Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. NCT00314652 | Completed | Phase 3 | United States | Purdue Pharma LP | 1999-06 |
| The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain. NCT00315887 | Completed | Phase 3 | United States | Purdue Pharma LP | 1999-04 |
| The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. NCT00315874 | Completed | Phase 3 | United States | Purdue Pharma LP | 1997-04 |
| The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. NCT00315848 | Completed | Phase 3 | United States | Purdue Pharma LP | 1996-11 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.